PLIANT THERAPEUTICS, INC. Debt Securities, Available-for-sale, Unrealized Loss
PLIANT THERAPEUTICS, INC. (PLRX) reported Debt Securities, Available-for-sale, Unrealized Loss of $2.46 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss · last filed 2022-11-08
- PLIANT THERAPEUTICS, INC. debt securities, available-for-sale, unrealized loss for the quarter ending 2022-09-30 was $1.20M, a 119500.00% increase year-over-year.
- PLIANT THERAPEUTICS, INC. debt securities, available-for-sale, unrealized loss for the quarter ending 2022-06-30 was $309.00K, a 2990.00% increase year-over-year.
- PLIANT THERAPEUTICS, INC. debt securities, available-for-sale, unrealized loss for the quarter ending 2022-03-31 was $950.00K, a 2467.57% increase year-over-year.
- PLIANT THERAPEUTICS, INC. debt securities, available-for-sale, unrealized loss for the quarter ending 2021-12-31 was $154.00K, a 755.56% increase year-over-year.
- PLIANT THERAPEUTICS, INC. debt securities, available-for-sale, unrealized loss for fiscal 2020 was $47.00K, a 2250.00% increase from fiscal 2019.
- PLIANT THERAPEUTICS, INC. debt securities, available-for-sale, unrealized loss for fiscal 2019 was $2.00K.
| Period end | Debt Securities, Available-for-sale, Unrealized Loss 3 month | Debt Securities, Available-for-sale, Unrealized Loss 6 month | Debt Securities, Available-for-sale, Unrealized Loss 9 month | Debt Securities, Available-for-sale, Unrealized Loss 12 month |
|---|---|---|---|---|
| 2022-09-30 | $1.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $1.50M derived: sum of 2 quarters · filed 2022-11-08 | $2.46M 10-Q · filed 2022-11-08 | $2.61M derived: sum of 4 quarters · filed 2022-11-08 |
| 2022-06-30 | $309.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $1.26M 10-Q · filed 2022-08-08 | $1.41M derived: sum of 3 quarters · filed 2022-11-08 | $1.41M derived: sum of 4 quarters · filed 2022-11-08 |
| 2022-03-31 | $950.00K 10-Q · filed 2022-05-09 | $1.10M derived: sum of 2 quarters · filed 2022-11-08 | $1.10M derived: sum of 3 quarters · filed 2022-11-08 | $1.11M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-12-31 | $154.00K derived: 10-Q 12 month − 10-Q 9 month · filed 2022-11-08 | $155.00K derived: sum of 2 quarters · filed 2022-11-08 | $165.00K derived: sum of 3 quarters · filed 2022-11-08 | $202.00K 10-Q · filed 2022-11-08 |
| 2021-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $11.00K derived: sum of 2 quarters · filed 2021-11-09 | $48.00K 10-Q · filed 2021-11-09 | $66.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2021-06-30 | $10.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $47.00K 10-Q · filed 2021-08-09 | $65.00K derived: sum of 3 quarters · filed 2022-03-01 | $58.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2021-03-31 | $37.00K 10-Q · filed 2021-05-10 | $55.00K derived: sum of 2 quarters · filed 2022-03-01 | $48.00K derived: sum of 3 quarters · filed 2022-03-01 | |
| 2020-12-31 | $18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $11.00K derived: sum of 2 quarters · filed 2022-03-01 | $47.00K 10-K · filed 2022-03-01 | |
| 2020-09-30 | -$7.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $29.00K 10-Q · filed 2020-11-10 | ||
| 2020-06-30 | $36.00K 10-Q · filed 2020-08-11 | |||
| 2019-12-31 | $2.00K 10-K · filed 2021-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |